nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CUBN—myometrium—ovarian cancer	0.00911	0.0327	CbGeAlD
Hydroxocobalamin—AMN—uterine cervix—ovarian cancer	0.00843	0.0303	CbGeAlD
Hydroxocobalamin—TCN2—myometrium—ovarian cancer	0.00737	0.0265	CbGeAlD
Hydroxocobalamin—CUBN—epithelium—ovarian cancer	0.00715	0.0257	CbGeAlD
Hydroxocobalamin—TCN1—uterine cervix—ovarian cancer	0.00639	0.0229	CbGeAlD
Hydroxocobalamin—TCN1—decidua—ovarian cancer	0.00608	0.0219	CbGeAlD
Hydroxocobalamin—MUT—myometrium—ovarian cancer	0.0058	0.0208	CbGeAlD
Hydroxocobalamin—TCN1—endometrium—ovarian cancer	0.00578	0.0208	CbGeAlD
Hydroxocobalamin—CASP9—decidua—ovarian cancer	0.0056	0.0201	CbGeAlD
Hydroxocobalamin—TCN2—decidua—ovarian cancer	0.00546	0.0196	CbGeAlD
Hydroxocobalamin—CUBN—female reproductive system—ovarian cancer	0.00531	0.0191	CbGeAlD
Hydroxocobalamin—MTRR—myometrium—ovarian cancer	0.00521	0.0187	CbGeAlD
Hydroxocobalamin—AMN—testis—ovarian cancer	0.00509	0.0183	CbGeAlD
Hydroxocobalamin—CUBN—female gonad—ovarian cancer	0.00483	0.0174	CbGeAlD
Hydroxocobalamin—MMAB—female reproductive system—ovarian cancer	0.00471	0.0169	CbGeAlD
Hydroxocobalamin—MMAA—female gonad—ovarian cancer	0.00457	0.0164	CbGeAlD
Hydroxocobalamin—MMAA—vagina—ovarian cancer	0.00454	0.0163	CbGeAlD
Hydroxocobalamin—MTR—myometrium—ovarian cancer	0.00454	0.0163	CbGeAlD
Hydroxocobalamin—TCN1—bone marrow—ovarian cancer	0.00452	0.0162	CbGeAlD
Hydroxocobalamin—MUT—uterine cervix—ovarian cancer	0.00451	0.0162	CbGeAlD
Hydroxocobalamin—CASP9—female reproductive system—ovarian cancer	0.0044	0.0158	CbGeAlD
Hydroxocobalamin—TCN1—vagina—ovarian cancer	0.00433	0.0155	CbGeAlD
Hydroxocobalamin—TCN2—female reproductive system—ovarian cancer	0.0043	0.0154	CbGeAlD
Hydroxocobalamin—MUT—decidua—ovarian cancer	0.0043	0.0154	CbGeAlD
Hydroxocobalamin—CUBN—testis—ovarian cancer	0.00429	0.0154	CbGeAlD
Hydroxocobalamin—MMAB—female gonad—ovarian cancer	0.00429	0.0154	CbGeAlD
Hydroxocobalamin—MMAB—vagina—ovarian cancer	0.00426	0.0153	CbGeAlD
Hydroxocobalamin—MUT—endometrium—ovarian cancer	0.00408	0.0147	CbGeAlD
Hydroxocobalamin—MMAA—testis—ovarian cancer	0.00406	0.0146	CbGeAlD
Hydroxocobalamin—MTRR—uterine cervix—ovarian cancer	0.00405	0.0146	CbGeAlD
Hydroxocobalamin—CASP9—female gonad—ovarian cancer	0.00401	0.0144	CbGeAlD
Hydroxocobalamin—CASP9—vagina—ovarian cancer	0.00398	0.0143	CbGeAlD
Hydroxocobalamin—MTRR—decidua—ovarian cancer	0.00386	0.0139	CbGeAlD
Hydroxocobalamin—MMAB—testis—ovarian cancer	0.0038	0.0137	CbGeAlD
Hydroxocobalamin—MUT—gonad—ovarian cancer	0.00378	0.0136	CbGeAlD
Hydroxocobalamin—MUT—uterus—ovarian cancer	0.00376	0.0135	CbGeAlD
Hydroxocobalamin—AMN—lymph node—ovarian cancer	0.00369	0.0133	CbGeAlD
Hydroxocobalamin—MTRR—endometrium—ovarian cancer	0.00367	0.0132	CbGeAlD
Hydroxocobalamin—CASP9—testis—ovarian cancer	0.00355	0.0128	CbGeAlD
Hydroxocobalamin—MTR—uterine cervix—ovarian cancer	0.00354	0.0127	CbGeAlD
Hydroxocobalamin—TCN2—testis—ovarian cancer	0.00347	0.0125	CbGeAlD
Hydroxocobalamin—MTRR—gonad—ovarian cancer	0.0034	0.0122	CbGeAlD
Hydroxocobalamin—MUT—female reproductive system—ovarian cancer	0.00338	0.0121	CbGeAlD
Hydroxocobalamin—MTRR—uterus—ovarian cancer	0.00338	0.0121	CbGeAlD
Hydroxocobalamin—MTR—decidua—ovarian cancer	0.00337	0.0121	CbGeAlD
Hydroxocobalamin—MTR—endometrium—ovarian cancer	0.0032	0.0115	CbGeAlD
Hydroxocobalamin—MUT—bone marrow—ovarian cancer	0.00319	0.0115	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—ovarian cancer	0.00311	0.0112	CbGeAlD
Hydroxocobalamin—MUT—female gonad—ovarian cancer	0.00308	0.011	CbGeAlD
Hydroxocobalamin—MUT—vagina—ovarian cancer	0.00306	0.011	CbGeAlD
Hydroxocobalamin—MTRR—female reproductive system—ovarian cancer	0.00304	0.0109	CbGeAlD
Hydroxocobalamin—MTR—gonad—ovarian cancer	0.00297	0.0107	CbGeAlD
Hydroxocobalamin—MTR—uterus—ovarian cancer	0.00295	0.0106	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—ovarian cancer	0.00294	0.0106	CbGeAlD
Hydroxocobalamin—MTRR—bone marrow—ovarian cancer	0.00287	0.0103	CbGeAlD
Hydroxocobalamin—MTRR—female gonad—ovarian cancer	0.00276	0.00993	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—ovarian cancer	0.00276	0.00991	CbGeAlD
Hydroxocobalamin—MTRR—vagina—ovarian cancer	0.00275	0.00987	CbGeAlD
Hydroxocobalamin—MUT—testis—ovarian cancer	0.00273	0.0098	CbGeAlD
Hydroxocobalamin—MTR—female reproductive system—ovarian cancer	0.00265	0.00952	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—ovarian cancer	0.00258	0.00925	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—ovarian cancer	0.00251	0.00903	CbGeAlD
Hydroxocobalamin—MTR—bone marrow—ovarian cancer	0.0025	0.00899	CbGeAlD
Hydroxocobalamin—MTRR—testis—ovarian cancer	0.00245	0.00881	CbGeAlD
Hydroxocobalamin—MTR—female gonad—ovarian cancer	0.00241	0.00866	CbGeAlD
Hydroxocobalamin—MTR—vagina—ovarian cancer	0.0024	0.00861	CbGeAlD
Hydroxocobalamin—MTR—testis—ovarian cancer	0.00214	0.00768	CbGeAlD
Hydroxocobalamin—MUT—lymph node—ovarian cancer	0.00198	0.0071	CbGeAlD
Hydroxocobalamin—MTRR—lymph node—ovarian cancer	0.00178	0.00638	CbGeAlD
Hydroxocobalamin—MTR—lymph node—ovarian cancer	0.00155	0.00557	CbGeAlD
Hydroxocobalamin—Anaphylactic shock—Topotecan—ovarian cancer	0.000877	0.00263	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Docetaxel—ovarian cancer	0.000874	0.00262	CcSEcCtD
Hydroxocobalamin—Infection—Topotecan—ovarian cancer	0.000872	0.00262	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Chlorambucil—ovarian cancer	0.000867	0.0026	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Topotecan—ovarian cancer	0.00086	0.00258	CcSEcCtD
Hydroxocobalamin—Oedema—Melphalan—ovarian cancer	0.000859	0.00258	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Melphalan—ovarian cancer	0.000859	0.00258	CcSEcCtD
Hydroxocobalamin—Extravasation—Doxorubicin—ovarian cancer	0.000858	0.00257	CcSEcCtD
Hydroxocobalamin—Infection—Melphalan—ovarian cancer	0.000853	0.00256	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000853	0.00256	CcSEcCtD
Hydroxocobalamin—Skin disorder—Topotecan—ovarian cancer	0.000852	0.00256	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000851	0.00255	CcSEcCtD
Hydroxocobalamin—Pain—Chlorambucil—ovarian cancer	0.000843	0.00253	CcSEcCtD
Hydroxocobalamin—Angioedema—Vinorelbine—ovarian cancer	0.00084	0.00252	CcSEcCtD
Hydroxocobalamin—Tachycardia—Melphalan—ovarian cancer	0.000838	0.00252	CcSEcCtD
Hydroxocobalamin—Skin disorder—Melphalan—ovarian cancer	0.000834	0.0025	CcSEcCtD
Hydroxocobalamin—Malaise—Vinorelbine—ovarian cancer	0.000829	0.00249	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Doxorubicin—ovarian cancer	0.000829	0.00249	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Chlorambucil—ovarian cancer	0.000812	0.00244	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Epirubicin—ovarian cancer	0.000804	0.00241	CcSEcCtD
Hydroxocobalamin—Urticaria—Chlorambucil—ovarian cancer	0.000783	0.00235	CcSEcCtD
Hydroxocobalamin—Chest pain—Vinorelbine—ovarian cancer	0.000783	0.00235	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Topotecan—ovarian cancer	0.000782	0.00235	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Chlorambucil—ovarian cancer	0.000779	0.00234	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000777	0.00233	CcSEcCtD
Hydroxocobalamin—Discomfort—Vinorelbine—ovarian cancer	0.000773	0.00232	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Topotecan—ovarian cancer	0.000772	0.00232	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Melphalan—ovarian cancer	0.000766	0.0023	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000757	0.00227	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Melphalan—ovarian cancer	0.000756	0.00227	CcSEcCtD
Hydroxocobalamin—Dysphagia—Docetaxel—ovarian cancer	0.000752	0.00226	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00075	0.00225	CcSEcCtD
Hydroxocobalamin—Pain—Topotecan—ovarian cancer	0.00075	0.00225	CcSEcCtD
Hydroxocobalamin—Infection—Vinorelbine—ovarian cancer	0.000746	0.00224	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—ovarian cancer	0.000744	0.00223	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000742	0.00223	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vinorelbine—ovarian cancer	0.000736	0.00221	CcSEcCtD
Hydroxocobalamin—Pain—Melphalan—ovarian cancer	0.000735	0.0022	CcSEcCtD
Hydroxocobalamin—Tachycardia—Vinorelbine—ovarian cancer	0.000732	0.0022	CcSEcCtD
Hydroxocobalamin—Skin disorder—Vinorelbine—ovarian cancer	0.000729	0.00219	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000726	0.00218	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Topotecan—ovarian cancer	0.000723	0.00217	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—ovarian cancer	0.00072	0.00216	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000702	0.00211	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Paclitaxel—ovarian cancer	0.0007	0.0021	CcSEcCtD
Hydroxocobalamin—Pruritus—Chlorambucil—ovarian cancer	0.000697	0.00209	CcSEcCtD
Hydroxocobalamin—Urticaria—Topotecan—ovarian cancer	0.000697	0.00209	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Paclitaxel—ovarian cancer	0.000696	0.00209	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Topotecan—ovarian cancer	0.000693	0.00208	CcSEcCtD
Hydroxocobalamin—Urticaria—Melphalan—ovarian cancer	0.000682	0.00205	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—ovarian cancer	0.000682	0.00204	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Chlorambucil—ovarian cancer	0.000674	0.00202	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Vinorelbine—ovarian cancer	0.000669	0.00201	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—ovarian cancer	0.000666	0.002	CcSEcCtD
Hydroxocobalamin—Eye disorder—Paclitaxel—ovarian cancer	0.000664	0.00199	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Paclitaxel—ovarian cancer	0.000659	0.00198	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—ovarian cancer	0.000653	0.00196	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000648	0.00194	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000647	0.00194	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Topotecan—ovarian cancer	0.000646	0.00194	CcSEcCtD
Hydroxocobalamin—Angiopathy—Paclitaxel—ovarian cancer	0.000645	0.00193	CcSEcCtD
Hydroxocobalamin—Pain—Vinorelbine—ovarian cancer	0.000642	0.00193	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Paclitaxel—ovarian cancer	0.000642	0.00193	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00064	0.00192	CcSEcCtD
Hydroxocobalamin—Chills—Paclitaxel—ovarian cancer	0.000637	0.00191	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Paclitaxel—ovarian cancer	0.000635	0.0019	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Melphalan—ovarian cancer	0.000633	0.0019	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—ovarian cancer	0.000631	0.00189	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—ovarian cancer	0.000628	0.00188	CcSEcCtD
Hydroxocobalamin—Mental disorder—Paclitaxel—ovarian cancer	0.000622	0.00187	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—ovarian cancer	0.000622	0.00187	CcSEcCtD
Hydroxocobalamin—Pruritus—Topotecan—ovarian cancer	0.000621	0.00186	CcSEcCtD
Hydroxocobalamin—Erythema—Paclitaxel—ovarian cancer	0.000618	0.00186	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Vinorelbine—ovarian cancer	0.000618	0.00186	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—ovarian cancer	0.000614	0.00184	CcSEcCtD
Hydroxocobalamin—Pruritus—Melphalan—ovarian cancer	0.000608	0.00182	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—ovarian cancer	0.000605	0.00181	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Topotecan—ovarian cancer	0.0006	0.0018	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000599	0.0018	CcSEcCtD
Hydroxocobalamin—Urticaria—Vinorelbine—ovarian cancer	0.000596	0.00179	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Docetaxel—ovarian cancer	0.000595	0.00178	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vinorelbine—ovarian cancer	0.000593	0.00178	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Docetaxel—ovarian cancer	0.000593	0.00178	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Docetaxel—ovarian cancer	0.00059	0.00177	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—ovarian cancer	0.000589	0.00177	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Melphalan—ovarian cancer	0.000588	0.00176	CcSEcCtD
Hydroxocobalamin—Nausea—Chlorambucil—ovarian cancer	0.000585	0.00176	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—ovarian cancer	0.000581	0.00174	CcSEcCtD
Hydroxocobalamin—Dizziness—Topotecan—ovarian cancer	0.00058	0.00174	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000576	0.00173	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000574	0.00172	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000568	0.00171	CcSEcCtD
Hydroxocobalamin—Agitation—Paclitaxel—ovarian cancer	0.000568	0.00171	CcSEcCtD
Hydroxocobalamin—Angioedema—Paclitaxel—ovarian cancer	0.000565	0.0017	CcSEcCtD
Hydroxocobalamin—Eye disorder—Docetaxel—ovarian cancer	0.000563	0.00169	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Docetaxel—ovarian cancer	0.000559	0.00168	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—ovarian cancer	0.000558	0.00168	CcSEcCtD
Hydroxocobalamin—Malaise—Paclitaxel—ovarian cancer	0.000558	0.00167	CcSEcCtD
Hydroxocobalamin—Rash—Topotecan—ovarian cancer	0.000553	0.00166	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000553	0.00166	CcSEcCtD
Hydroxocobalamin—Dermatitis—Topotecan—ovarian cancer	0.000553	0.00166	CcSEcCtD
Hydroxocobalamin—Headache—Topotecan—ovarian cancer	0.00055	0.00165	CcSEcCtD
Hydroxocobalamin—Angiopathy—Docetaxel—ovarian cancer	0.000546	0.00164	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—ovarian cancer	0.000545	0.00164	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Docetaxel—ovarian cancer	0.000544	0.00163	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Docetaxel—ovarian cancer	0.000543	0.00163	CcSEcCtD
Hydroxocobalamin—Rash—Melphalan—ovarian cancer	0.000542	0.00163	CcSEcCtD
Hydroxocobalamin—Dermatitis—Melphalan—ovarian cancer	0.000541	0.00162	CcSEcCtD
Hydroxocobalamin—Chills—Docetaxel—ovarian cancer	0.00054	0.00162	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Docetaxel—ovarian cancer	0.000538	0.00161	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—ovarian cancer	0.000534	0.0016	CcSEcCtD
Hydroxocobalamin—Pruritus—Vinorelbine—ovarian cancer	0.000531	0.00159	CcSEcCtD
Hydroxocobalamin—Mental disorder—Docetaxel—ovarian cancer	0.000528	0.00158	CcSEcCtD
Hydroxocobalamin—Chest pain—Paclitaxel—ovarian cancer	0.000527	0.00158	CcSEcCtD
Hydroxocobalamin—Erythema—Docetaxel—ovarian cancer	0.000524	0.00157	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000523	0.00157	CcSEcCtD
Hydroxocobalamin—Nausea—Topotecan—ovarian cancer	0.000521	0.00156	CcSEcCtD
Hydroxocobalamin—Discomfort—Paclitaxel—ovarian cancer	0.00052	0.00156	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—ovarian cancer	0.000517	0.00155	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vinorelbine—ovarian cancer	0.000513	0.00154	CcSEcCtD
Hydroxocobalamin—Nausea—Melphalan—ovarian cancer	0.00051	0.00153	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—ovarian cancer	0.000507	0.00152	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000505	0.00151	CcSEcCtD
Hydroxocobalamin—Oedema—Paclitaxel—ovarian cancer	0.000505	0.00151	CcSEcCtD
Hydroxocobalamin—Infection—Paclitaxel—ovarian cancer	0.000501	0.0015	CcSEcCtD
Hydroxocobalamin—Dizziness—Vinorelbine—ovarian cancer	0.000496	0.00149	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Paclitaxel—ovarian cancer	0.000495	0.00149	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—ovarian cancer	0.000494	0.00148	CcSEcCtD
Hydroxocobalamin—Tachycardia—Paclitaxel—ovarian cancer	0.000493	0.00148	CcSEcCtD
Hydroxocobalamin—Skin disorder—Paclitaxel—ovarian cancer	0.00049	0.00147	CcSEcCtD
Hydroxocobalamin—Rash—Vinorelbine—ovarian cancer	0.000473	0.00142	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vinorelbine—ovarian cancer	0.000473	0.00142	CcSEcCtD
Hydroxocobalamin—Headache—Vinorelbine—ovarian cancer	0.00047	0.00141	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—ovarian cancer	0.00047	0.00141	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Paclitaxel—ovarian cancer	0.00045	0.00135	CcSEcCtD
Hydroxocobalamin—Chest pain—Docetaxel—ovarian cancer	0.000446	0.00134	CcSEcCtD
Hydroxocobalamin—Nausea—Vinorelbine—ovarian cancer	0.000446	0.00134	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Paclitaxel—ovarian cancer	0.000444	0.00133	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000443	0.00133	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000436	0.00131	CcSEcCtD
Hydroxocobalamin—Pain—Paclitaxel—ovarian cancer	0.000432	0.0013	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000428	0.00128	CcSEcCtD
Hydroxocobalamin—Oedema—Docetaxel—ovarian cancer	0.000428	0.00128	CcSEcCtD
Hydroxocobalamin—Infection—Docetaxel—ovarian cancer	0.000425	0.00128	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Docetaxel—ovarian cancer	0.00042	0.00126	CcSEcCtD
Hydroxocobalamin—Tachycardia—Docetaxel—ovarian cancer	0.000418	0.00125	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000416	0.00125	CcSEcCtD
Hydroxocobalamin—Skin disorder—Docetaxel—ovarian cancer	0.000416	0.00125	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—ovarian cancer	0.000401	0.0012	CcSEcCtD
Hydroxocobalamin—Urticaria—Paclitaxel—ovarian cancer	0.000401	0.0012	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—ovarian cancer	0.0004	0.0012	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Paclitaxel—ovarian cancer	0.000399	0.0012	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—ovarian cancer	0.000398	0.00119	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Docetaxel—ovarian cancer	0.000381	0.00114	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—ovarian cancer	0.00038	0.00114	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—ovarian cancer	0.000377	0.00113	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Docetaxel—ovarian cancer	0.000377	0.00113	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000372	0.00112	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000371	0.00111	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—ovarian cancer	0.00037	0.00111	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000369	0.00111	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—ovarian cancer	0.000369	0.00111	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—ovarian cancer	0.000368	0.00111	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—ovarian cancer	0.000367	0.0011	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—ovarian cancer	0.000366	0.0011	CcSEcCtD
Hydroxocobalamin—Pain—Docetaxel—ovarian cancer	0.000366	0.0011	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—ovarian cancer	0.000364	0.00109	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—ovarian cancer	0.000363	0.00109	CcSEcCtD
Hydroxocobalamin—Pruritus—Paclitaxel—ovarian cancer	0.000357	0.00107	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—ovarian cancer	0.000356	0.00107	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—ovarian cancer	0.000354	0.00106	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Docetaxel—ovarian cancer	0.000353	0.00106	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—ovarian cancer	0.000351	0.00105	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—ovarian cancer	0.000349	0.00105	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Paclitaxel—ovarian cancer	0.000345	0.00104	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—ovarian cancer	0.000341	0.00102	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—ovarian cancer	0.000339	0.00102	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000339	0.00102	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Docetaxel—ovarian cancer	0.000338	0.00101	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—ovarian cancer	0.000337	0.00101	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—ovarian cancer	0.000336	0.00101	CcSEcCtD
Hydroxocobalamin—Dizziness—Paclitaxel—ovarian cancer	0.000334	0.001	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—ovarian cancer	0.000329	0.000988	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000328	0.000984	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—ovarian cancer	0.000327	0.000982	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—ovarian cancer	0.000325	0.000975	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—ovarian cancer	0.000319	0.000957	CcSEcCtD
Hydroxocobalamin—Rash—Paclitaxel—ovarian cancer	0.000318	0.000955	CcSEcCtD
Hydroxocobalamin—Dermatitis—Paclitaxel—ovarian cancer	0.000318	0.000954	CcSEcCtD
Hydroxocobalamin—Headache—Paclitaxel—ovarian cancer	0.000316	0.000949	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Docetaxel—ovarian cancer	0.000315	0.000946	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000304	0.000911	CcSEcCtD
Hydroxocobalamin—Pruritus—Docetaxel—ovarian cancer	0.000303	0.000908	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—ovarian cancer	0.000301	0.000903	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—ovarian cancer	0.000301	0.000902	CcSEcCtD
Hydroxocobalamin—Nausea—Paclitaxel—ovarian cancer	0.0003	0.0009	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000299	0.000897	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—ovarian cancer	0.000297	0.000892	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—ovarian cancer	0.000295	0.000885	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Docetaxel—ovarian cancer	0.000293	0.000878	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000289	0.000866	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—ovarian cancer	0.000289	0.000866	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—ovarian cancer	0.000287	0.00086	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—ovarian cancer	0.000283	0.000849	CcSEcCtD
Hydroxocobalamin—Dizziness—Docetaxel—ovarian cancer	0.000283	0.000849	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—ovarian cancer	0.000282	0.000845	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—ovarian cancer	0.00028	0.000841	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—ovarian cancer	0.000279	0.000836	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000277	0.00083	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—ovarian cancer	0.000275	0.000826	CcSEcCtD
Hydroxocobalamin—Rash—Docetaxel—ovarian cancer	0.00027	0.000809	CcSEcCtD
Hydroxocobalamin—Dermatitis—Docetaxel—ovarian cancer	0.00027	0.000809	CcSEcCtD
Hydroxocobalamin—Headache—Docetaxel—ovarian cancer	0.000268	0.000804	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—ovarian cancer	0.000267	0.000801	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000267	0.000801	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—ovarian cancer	0.000265	0.000796	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000262	0.000786	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—ovarian cancer	0.000261	0.000782	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—ovarian cancer	0.000259	0.000778	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—ovarian cancer	0.000257	0.000772	CcSEcCtD
Hydroxocobalamin—Nausea—Docetaxel—ovarian cancer	0.000254	0.000763	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—ovarian cancer	0.000254	0.000762	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000249	0.000748	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—ovarian cancer	0.000247	0.00074	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—ovarian cancer	0.000238	0.000714	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—ovarian cancer	0.000238	0.000714	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—ovarian cancer	0.000235	0.000705	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000231	0.000692	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—ovarian cancer	0.000229	0.000688	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—ovarian cancer	0.000228	0.000685	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—ovarian cancer	0.000228	0.000684	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—ovarian cancer	0.00022	0.00066	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—ovarian cancer	0.000213	0.000638	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—ovarian cancer	0.000212	0.000636	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—ovarian cancer	0.000211	0.000633	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—ovarian cancer	0.000204	0.000613	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—ovarian cancer	0.000197	0.000592	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000197	0.00059	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—ovarian cancer	0.000191	0.000573	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—ovarian cancer	0.000189	0.000567	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—ovarian cancer	0.000183	0.000548	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—ovarian cancer	0.000182	0.000546	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—ovarian cancer	0.000182	0.000545	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—ovarian cancer	0.000181	0.000542	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—ovarian cancer	0.000177	0.00053	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—ovarian cancer	0.000171	0.000514	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—ovarian cancer	0.000168	0.000505	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—ovarian cancer	0.000168	0.000505	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—ovarian cancer	0.000167	0.000502	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—ovarian cancer	0.000159	0.000476	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—PIK3CD—ovarian cancer	6.58e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MAPK3—ovarian cancer	6.57e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CDKN1B—ovarian cancer	6.55e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MTOR—ovarian cancer	6.54e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CB—ovarian cancer	6.54e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTEN—ovarian cancer	6.54e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—ovarian cancer	6.47e-05	0.000167	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTEN—ovarian cancer	6.44e-05	0.000166	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—ovarian cancer	6.39e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PIK3CA—ovarian cancer	6.38e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PGR—ovarian cancer	6.37e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—ovarian cancer	6.37e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—ovarian cancer	6.35e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—ovarian cancer	6.35e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6ST—ovarian cancer	6.35e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CB—ovarian cancer	6.33e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CB—ovarian cancer	6.28e-05	0.000162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MTOR—ovarian cancer	6.28e-05	0.000162	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CG—ovarian cancer	6.27e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MAPK1—ovarian cancer	6.25e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—ovarian cancer	6.25e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—ovarian cancer	6.19e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CTNNB1—ovarian cancer	6.19e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CDKN1B—ovarian cancer	6.14e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—STAT3—ovarian cancer	6.13e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—STAT3—ovarian cancer	6.13e-05	0.000158	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—ovarian cancer	6.11e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—ovarian cancer	6.11e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APC—ovarian cancer	6.1e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTEN—ovarian cancer	6.03e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PARP1—ovarian cancer	5.92e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—ovarian cancer	5.9e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—ovarian cancer	5.9e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1B—ovarian cancer	5.9e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MAPK3—ovarian cancer	5.85e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MAPK3—ovarian cancer	5.85e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CB—ovarian cancer	5.85e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—STAT3—ovarian cancer	5.85e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PIK3CA—ovarian cancer	5.83e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PIK3CA—ovarian cancer	5.83e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—ovarian cancer	5.83e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—ovarian cancer	5.81e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CTNNB1—ovarian cancer	5.8e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTEN—ovarian cancer	5.74e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTEN—ovarian cancer	5.74e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTOR—ovarian cancer	5.73e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CB—ovarian cancer	5.73e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—ovarian cancer	5.71e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—ovarian cancer	5.69e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—ovarian cancer	5.69e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTEN—ovarian cancer	5.65e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—ovarian cancer	5.65e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CAV1—ovarian cancer	5.61e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MAPK3—ovarian cancer	5.58e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MAPK1—ovarian cancer	5.57e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MAPK1—ovarian cancer	5.57e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—ovarian cancer	5.57e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—ovarian cancer	5.57e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CD—ovarian cancer	5.51e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—ovarian cancer	5.47e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—ovarian cancer	5.45e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—ovarian cancer	5.43e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—ovarian cancer	5.43e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—ovarian cancer	5.42e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TLR4—ovarian cancer	5.4e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—ovarian cancer	5.4e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—ovarian cancer	5.4e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—ovarian cancer	5.39e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—ovarian cancer	5.38e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1B—ovarian cancer	5.38e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CD—ovarian cancer	5.36e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—ovarian cancer	5.34e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MAPK1—ovarian cancer	5.31e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—ovarian cancer	5.31e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—ovarian cancer	5.26e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—ovarian cancer	5.26e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—ovarian cancer	5.21e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6ST—ovarian cancer	5.18e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—ovarian cancer	5.17e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—ovarian cancer	5.17e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK3—ovarian cancer	5.15e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—ovarian cancer	5.11e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—ovarian cancer	5.08e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—ovarian cancer	5.05e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—ovarian cancer	5.04e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CAV1—ovarian cancer	5.04e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—ovarian cancer	5.02e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—ovarian cancer	5.02e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—ovarian cancer	5.01e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—ovarian cancer	4.95e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK1—ovarian cancer	4.9e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—ovarian cancer	4.9e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—ovarian cancer	4.89e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—ovarian cancer	4.89e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—ovarian cancer	4.84e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—ovarian cancer	4.83e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—ovarian cancer	4.83e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK3—ovarian cancer	4.83e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PPP2R1A—ovarian cancer	4.8e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—ovarian cancer	4.8e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—ovarian cancer	4.8e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6ST—ovarian cancer	4.78e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—ovarian cancer	4.77e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—ovarian cancer	4.77e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—ovarian cancer	4.74e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTOR—ovarian cancer	4.67e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—ovarian cancer	4.67e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—ovarian cancer	4.63e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—ovarian cancer	4.61e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK1—ovarian cancer	4.6e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—ovarian cancer	4.6e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APC—ovarian cancer	4.59e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—ovarian cancer	4.58e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—ovarian cancer	4.54e-05	0.000117	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—ovarian cancer	4.49e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—ovarian cancer	4.47e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—ovarian cancer	4.47e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—ovarian cancer	4.43e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—ovarian cancer	4.43e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—ovarian cancer	4.42e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—ovarian cancer	4.41e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—ovarian cancer	4.39e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—ovarian cancer	4.37e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—ovarian cancer	4.36e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—ovarian cancer	4.34e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—ovarian cancer	4.28e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—ovarian cancer	4.28e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—ovarian cancer	4.27e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—ovarian cancer	4.26e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK3—ovarian cancer	4.23e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—ovarian cancer	4.17e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—ovarian cancer	4.15e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—ovarian cancer	4.14e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—ovarian cancer	4.12e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—ovarian cancer	4.08e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—ovarian cancer	4.05e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—ovarian cancer	4.05e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—ovarian cancer	4.04e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—ovarian cancer	4.04e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK1—ovarian cancer	4.03e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—ovarian cancer	4.03e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—ovarian cancer	3.99e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—ovarian cancer	3.99e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—ovarian cancer	3.99e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—ovarian cancer	3.95e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—ovarian cancer	3.95e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—ovarian cancer	3.94e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—ovarian cancer	3.91e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—ovarian cancer	3.86e-05	9.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—ovarian cancer	3.86e-05	9.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—ovarian cancer	3.83e-05	9.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—ovarian cancer	3.82e-05	9.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—ovarian cancer	3.81e-05	9.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MTOR—ovarian cancer	3.81e-05	9.81e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—ovarian cancer	3.8e-05	9.79e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—ovarian cancer	3.77e-05	9.7e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—ovarian cancer	3.77e-05	9.7e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—ovarian cancer	3.71e-05	9.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—ovarian cancer	3.69e-05	9.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—ovarian cancer	3.61e-05	9.3e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—ovarian cancer	3.6e-05	9.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—ovarian cancer	3.58e-05	9.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—ovarian cancer	3.57e-05	9.18e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—ovarian cancer	3.56e-05	9.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—ovarian cancer	3.54e-05	9.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—ovarian cancer	3.53e-05	9.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CAV1—ovarian cancer	3.53e-05	9.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTOR—ovarian cancer	3.52e-05	9.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—ovarian cancer	3.52e-05	9.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—ovarian cancer	3.5e-05	9.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—ovarian cancer	3.49e-05	9e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—ovarian cancer	3.48e-05	8.95e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK3—ovarian cancer	3.45e-05	8.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—ovarian cancer	3.4e-05	8.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—ovarian cancer	3.38e-05	8.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—ovarian cancer	3.38e-05	8.7e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—ovarian cancer	3.36e-05	8.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6ST—ovarian cancer	3.35e-05	8.62e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—ovarian cancer	3.31e-05	8.51e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—ovarian cancer	3.31e-05	8.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—ovarian cancer	3.3e-05	8.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—ovarian cancer	3.29e-05	8.48e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK1—ovarian cancer	3.28e-05	8.45e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—ovarian cancer	3.28e-05	8.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—ovarian cancer	3.26e-05	8.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—ovarian cancer	3.23e-05	8.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—ovarian cancer	3.22e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APC—ovarian cancer	3.22e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—ovarian cancer	3.15e-05	8.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—ovarian cancer	3.13e-05	8.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—ovarian cancer	3.12e-05	8.03e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—ovarian cancer	3.1e-05	7.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—ovarian cancer	3.09e-05	7.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—ovarian cancer	3.04e-05	7.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—ovarian cancer	2.94e-05	7.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—ovarian cancer	2.94e-05	7.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—ovarian cancer	2.93e-05	7.53e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—ovarian cancer	2.91e-05	7.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—ovarian cancer	2.85e-05	7.35e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—ovarian cancer	2.85e-05	7.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—ovarian cancer	2.83e-05	7.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK3—ovarian cancer	2.81e-05	7.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—ovarian cancer	2.72e-05	7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—ovarian cancer	2.71e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK1—ovarian cancer	2.68e-05	6.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—ovarian cancer	2.68e-05	6.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—ovarian cancer	2.64e-05	6.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK3—ovarian cancer	2.6e-05	6.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—ovarian cancer	2.53e-05	6.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—ovarian cancer	2.53e-05	6.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—ovarian cancer	2.52e-05	6.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—ovarian cancer	2.5e-05	6.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK1—ovarian cancer	2.47e-05	6.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—ovarian cancer	2.47e-05	6.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTOR—ovarian cancer	2.46e-05	6.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—ovarian cancer	2.46e-05	6.34e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—ovarian cancer	2.39e-05	6.16e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—ovarian cancer	2.39e-05	6.14e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—ovarian cancer	2.37e-05	6.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—ovarian cancer	2.33e-05	6.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—ovarian cancer	2.33e-05	5.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—ovarian cancer	2.32e-05	5.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—ovarian cancer	2.31e-05	5.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—ovarian cancer	2.27e-05	5.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—ovarian cancer	2.26e-05	5.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—ovarian cancer	2.21e-05	5.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—ovarian cancer	2.18e-05	5.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—ovarian cancer	2.15e-05	5.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—ovarian cancer	2.14e-05	5.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—ovarian cancer	2.14e-05	5.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—ovarian cancer	2.13e-05	5.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—ovarian cancer	2.06e-05	5.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—ovarian cancer	1.98e-05	5.11e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—ovarian cancer	1.95e-05	5.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—ovarian cancer	1.92e-05	4.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—ovarian cancer	1.9e-05	4.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—ovarian cancer	1.9e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—ovarian cancer	1.9e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—ovarian cancer	1.9e-05	4.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK3—ovarian cancer	1.82e-05	4.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—ovarian cancer	1.77e-05	4.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—ovarian cancer	1.75e-05	4.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK1—ovarian cancer	1.73e-05	4.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—ovarian cancer	1.73e-05	4.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—ovarian cancer	1.63e-05	4.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—ovarian cancer	1.5e-05	3.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—ovarian cancer	1.45e-05	3.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—ovarian cancer	1.39e-05	3.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—ovarian cancer	1.33e-05	3.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—ovarian cancer	1.23e-05	3.16e-05	CbGpPWpGaD
